LeonaBio (LONA) Other Operating Expenses (2023 - 2026)

LeonaBio (LONA) has 4 years of Other Operating Expenses data on file, last reported at -$929000.0 in Q1 2026.

• On a quarterly basis, Other Operating Expenses rose 87.87% year-over-year to -$929000.0 in Q1 2026; TTM through Mar 2026 was $80.0 million, a 83.77% increase from a year earlier, with the FY2025 full-year figure at $68.1 million, changed N/A from the prior year.
• Other Operating Expenses for Q1 2026 stood at -$929000.0, down from $86.4 million in the prior quarter.
• Over the last five years, Other Operating Expenses for LONA reached as high as $86.4 million in Q4 2025 and fell as low as -$24.8 million in Q1 2024.
• Historically, Other Operating Expenses has averaged $12.6 million across 4 years, with a median of -$3.2 million in 2025.
• Across the five-year window, Other Operating Expenses jumped 4636.81% in 2024 and climbed 14.02% in 2025, its largest moves.
• Year by year, Other Operating Expenses stood at $1.6 million in 2023, then soared by 4636.81% to $75.8 million in 2024, then grew by 14.02% to $86.4 million in 2025, then tumbled by 101.08% to -$929000.0 in 2026.
• Per Business Quant data, the three most recent Other Operating Expenses figures were -$929000.0 in Q1 2026, $86.4 million in Q4 2025, and -$5.5 million in Q2 2025.